16th Annual International Ultmann Chicago Lymphoma Symposium

Chicago, IL US
April 12, 2019 to April 13, 2019
The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.

We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers. Next year’s program offered in 2019 represents the 16th IUCLS.

This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. The format of the meeting includes a combination of expert presentations, interactive case discussions, poster/abstract presentations, and an opportunity for question-and-answer debates. The IUCLS is a two-day meeting held Friday afternoon and Saturday morning and early afternoon. Friday afternoon concentrates on the scientific and translational aspects of lymphoma, while Saturday has a clinical focus.

Learn more at the symposium website!

Target Audience

This activity is designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists and the other healthcare professionals interested in the treatment and diagnosis of lymphoma.

Learning Objectives

At the conclusion of this educational activity, participants will be able to:

  • Distinguish between the different treatment approaches for newly diagnosed T-cell lymphoma and mantle cell lymphoma;
  • Discuss the role of allogeneic stem cell transplant in Hodgkin lymphoma treatment;
  • Identify patient characteristics best suited for CAR T-cell treatment;
  • Differentiate between the different lymphoma staging and re-staging classifications to develop an appropriate patient treatment plan; 
  • Evaluate the different treatment options for follicular lymphoma and the risk of transformation to other cancers;
  • State key environmental and genetics risks for lymphoma and the roles they play in lymphoid malignancies;
  • Outline key molecular and cytogenetic information in order to determine best treatment options for chronic lymphocytic leukemia;
  • Determine short and long-term toxicities of cardiotoxic agents used in lymphoma treatment;
  • Describe how epigenetic targets in lymphoid cancers can be used to improve patient outcomes;
  • List non-chemotherapy options for follicular lymphoma.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Sara Moellering
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
(773) 702-0016
Event starts: 
04/12/2019 - 12:00pm
Event ends: 
04/13/2019 - 3:00pm
Activity opens: 
Activity expires: 
InterContinental Magnificent Mile
505 North Michigan Avenue
Chicago, IL 60611
United States
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

CLAIMING CREDIT: Click the button below!
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

Please login or create an account to proceed.